secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-05-15T20:46:48+00:00
Accession:  0001193125-26-227059
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics holds annual meeting post 1-for-25 reverse split; all proposals pass
--------------------------------------------------------------------------------

- All six directors elected; votes for ranged from 11.9M to 12.4M; broker non-votes ~50.8M.
- Ratification of CBIZ CPAs as auditor for 2026 approved with 60.9M in favor.
- Advisory say-on-pay approved with 10.4M for, 3.4M against.
- Sixth amendment to 2020 Stock Incentive Plan approved (7.98M for, 5.65M against).
- Meeting held after 1-for-25 reverse split effective April 2, 2026; vote results on pre-split share count.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526227059/0001193125-26-227059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526227059/pstv-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-227059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer